Article
Gene Therapy For Beta-Thalassemia: Updated Perspectives
1 Sept 2019
Abstract excerpt
Allogeneic hematopoietic stem cell transplantation was until very recently, the only permanent curative option available for patients suffering from transfusion-dependent beta-thalassemia. Gene therapy, by autologous transplantation of genetically modified hematopoietic stem cells, currently represents a novel therapeutic promise, after many years of extensive preclinical research for the optimization of gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
